1091 related articles for article (PubMed ID: 28115590)
21. Negative Immune Regulator TIPE2 Promotes M2 Macrophage Differentiation through the Activation of PI3K-AKT Signaling Pathway.
Liu R; Fan T; Geng W; Chen YH; Ruan Q; Zhang C
PLoS One; 2017; 12(1):e0170666. PubMed ID: 28122045
[TBL] [Abstract][Full Text] [Related]
22. [Dermatological implications of the PI3K pathway].
Dereure O
Ann Dermatol Venereol; 2015 Oct; 142(10):622-3. PubMed ID: 26001484
[No Abstract] [Full Text] [Related]
23. PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update.
Makker A; Goel MM; Mahdi AA
J Mol Endocrinol; 2014 Dec; 53(3):R103-18. PubMed ID: 25312969
[TBL] [Abstract][Full Text] [Related]
24. Luteolin Regulates Macrophage Polarization via the PI3K/Akt Pathway to Inhibit the Apoptosis Stimulated by Angiotensin II.
Jiang Q; Pan D; Yang Y; Hu Y; Fang L; Shang P; Xia Y; Li D
Curr Pharm Biotechnol; 2018; 19(5):428-437. PubMed ID: 29956625
[TBL] [Abstract][Full Text] [Related]
25. The TSC-mTOR pathway regulates macrophage polarization.
Byles V; Covarrubias AJ; Ben-Sahra I; Lamming DW; Sabatini DM; Manning BD; Horng T
Nat Commun; 2013; 4():2834. PubMed ID: 24280772
[TBL] [Abstract][Full Text] [Related]
26. Contribution of PKB/AKT signaling to thyroid cancer.
Viglietto G; Amodio N; Malanga D; Scrima M; De Marco C
Front Biosci (Landmark Ed); 2011 Jan; 16(4):1461-87. PubMed ID: 21196242
[TBL] [Abstract][Full Text] [Related]
27. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
28. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
29.
Zhang T; Zhang Y; Yang Z; Jiang Y; Sun L; Huang D; Tian M; Shen Y; Deng J; Hou J; Ma Y
Pathog Glob Health; 2023 Jun; 117(4):409-416. PubMed ID: 35876088
[TBL] [Abstract][Full Text] [Related]
30. PI3K/AKT signaling and systemic autoimmunity.
Patel RK; Mohan C
Immunol Res; 2005; 31(1):47-55. PubMed ID: 15591622
[TBL] [Abstract][Full Text] [Related]
31. High salt reduces the activation of IL-4- and IL-13-stimulated macrophages.
Binger KJ; Gebhardt M; Heinig M; Rintisch C; Schroeder A; Neuhofer W; Hilgers K; Manzel A; Schwartz C; Kleinewietfeld M; Voelkl J; Schatz V; Linker RA; Lang F; Voehringer D; Wright MD; Hubner N; Dechend R; Jantsch J; Titze J; Müller DN
J Clin Invest; 2015 Nov; 125(11):4223-38. PubMed ID: 26485286
[TBL] [Abstract][Full Text] [Related]
32. PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains.
Gao X; Lowry PR; Zhou X; Depry C; Wei Z; Wong GW; Zhang J
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14509-14. PubMed ID: 21873248
[TBL] [Abstract][Full Text] [Related]
33. Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.
Babaev VR; Ding L; Zhang Y; May JM; Ramsey SA; Vickers KC; Linton MF
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):156-169. PubMed ID: 30567482
[TBL] [Abstract][Full Text] [Related]
34. What controls PTEN and what it controls (in prostate cancer).
Ghosh PM
Asian J Androl; 2012 Jan; 14(1):130-1. PubMed ID: 21946231
[No Abstract] [Full Text] [Related]
35. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
36. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
37. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
[TBL] [Abstract][Full Text] [Related]
38. AKT mediated glycolytic shift regulates autophagy in classically activated macrophages.
Matta SK; Kumar D
Int J Biochem Cell Biol; 2015 Sep; 66():121-33. PubMed ID: 26222186
[TBL] [Abstract][Full Text] [Related]
39. Advanced oxidation protein products impair autophagic flux in macrophage by inducing lysosomal dysfunction via activation of PI3K-Akt-mTOR pathway in Crohn's disease.
Liao Y; Xu J; Qin B; Shi J; Qin C; Xie F; Ou S; Tang J; Wang W; Wu F; Bai L
Free Radic Biol Med; 2021 Aug; 172():33-47. PubMed ID: 34029692
[TBL] [Abstract][Full Text] [Related]
40. GM3 suppresses anchorage-independent growth via Rho GDP dissociation inhibitor beta in melanoma B16 cells.
Wang P; Xu S; Wang Y; Wu P; Zhang J; Sato T; Yamagata S; Yamagata T
Cancer Sci; 2011 Aug; 102(8):1476-85. PubMed ID: 21518140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
